Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil helped regrow eyebrows in women with Frontal Fibrosing Alopecia.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

No treatment works for everyone, and emotional support is crucial.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

A 7-year-old girl experienced temporary hair loss due to radiation, with signs of possible hair regrowth.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Eclipta alba can be used in products to treat hair loss.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

New alopecia treatments aim for better results and fewer side effects.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.